hotspot -WSS

hotspot

author：comprehensive 2025-09-14 21:55:00 - browse：7

Are venture capitalists OK? Are bolt-ons good for business? And when is it safe to say someone overpaid?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss how biotech’s downturn has made life difficult not just for startups but also the VCs they rely on for much-needed funding. We also take a look at Gilead Sciences’ struggle to turn itself into an oncology company and the latest biotech to get bought out by a major pharma firm.

For more on what we cover, here’s more on Gilead; here’s the news on Inhibrx; here’s the latest on biotech venture capital; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： 'The Exorcist' director William Friedkin dead at 87

knowledge

WSS

Arena BioWorks launches in Cambridge to speed drug discovery

JPM 2024: Biotech’s most prolific dealmaker sees a rosy 2024

Moderna hits safety problems in bold bid to reinvent medicine

In shift, Texas to cover initial consult for Afghan baby's gene therapy

Arena BioWorks launches in Cambridge to speed drug discovery

Study suggests new cause of Down syndrome: cells linked to aging

focus

hotspot

knowledge

At least 13 dead in Texas as scorching temps continue

At JPM 2024, hospital systems pitch financial strength to investors

Medicare proposal to cover medical devices draws a mixed reaction

Trump Jan. 6 attorney John Lauro is ex

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Novavax promises a turnaround & Lilly roils the obesity market

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Walensky prepares to leave CDC — and Congress — behind

The UK government moves asylum

knowledge

Nonprofit, backed by Microsoft, to certify AI tools in health care

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

Ascension's ugly legal battle over care for poor patients in Texas

Biden will tout long

Ascension's ugly legal battle over care for poor patients in Texas

Study suggests new cause of Down syndrome: cells linked to aging

knowledge

knowledge

knowledge

explore